阿斯佩拉库林A的总合成
Toyoharu Kobayashi1, Yuya Teshigahara1, Momoyo Sakakibara1
1School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Tokyo 192-0392, Japan.
Organic letters
|June 13, 2023
概括
研究人员实现了阿斯佩拉库林A的总合成,这是一种乳的sessquiterpenoid. 这种新的合成涉及17个步骤和关键反应,如约翰逊-克莱森重组.
科学领域:
- 有机化学 有机化学
- 自然产品的合成自然产品的合成
背景情况:
- 阿斯佩拉库林A是一种具有独特分子架构的六类乳.
- 复杂的自然产品的合成在有机化学中提出了重大挑战.
研究的目的:
- 为了实现阿斯佩拉库林A的第一个全血细胞合成,A.
- 开发一种高效的合成路径,适应进一步的结构改造.
主要方法:
- 合成开始于3-甲基-2-cyclopentenone.
- 关键的转换包括约翰逊-克莱森重组,用于构建四级碳中心.
- 采用了立体控制的化和酸介导的米乳化.
主要成果:
- 成功完成了17个步骤的阿斯佩拉库林A的全体合成.
- 合成建立了一个强大的方法来组装核心结构.
- 通过合成证实了阿斯佩拉库林A的前所未有的结构.
结论:
- 阿斯佩拉库林A的总合成为进一步的化学探索提供了宝贵的基础.
- 这种合成路线突出了约翰逊-克莱森重组在复杂分子构造中的实用性.
更多相关视频
11:44Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities
Published on: October 2, 2018
12.7K
09:07Single-Step Enrichment of a TAP-Tagged Histone Deacetylase of the Filamentous Fungus Aspergillus nidulans for Enzymatic Activity Assay
Published on: May 1, 2019
6.8K
相关概念视频
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Peptidoglycan Synthesis
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
